SVA vs. PLI, ABCN, FRX, EMC, MDNA, BCT, IPA, ONC, SCYB, and COM
Should you be buying Sernova stock or one of its competitors? The main competitors of Sernova include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Fennec Pharmaceuticals (FRX), Emblem (EMC), Medicenna Therapeutics (MDNA), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry.
ProMetic Life Sciences (TSE:PLI) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment.
In the previous week, Sernova had 1 more articles in the media than ProMetic Life Sciences. MarketBeat recorded 1 mentions for Sernova and 0 mentions for ProMetic Life Sciences. ProMetic Life Sciences' average media sentiment score of 0.84 beat Sernova's score of 0.00 indicating that Sernova is being referred to more favorably in the news media.
Sernova has lower revenue, but higher earnings than ProMetic Life Sciences. Sernova is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks.
Sernova has a consensus price target of C$1.50, suggesting a potential upside of 305.41%.
ProMetic Life Sciences received 434 more outperform votes than Sernova when rated by MarketBeat users. However, 88.89% of users gave Sernova an outperform vote while only 67.69% of users gave ProMetic Life Sciences an outperform vote.
Sernova's return on equity of 0.00% beat ProMetic Life Sciences' return on equity.
0.1% of Sernova shares are held by institutional investors. 12.7% of Sernova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Sernova beats ProMetic Life Sciences on 7 of the 12 factors compared between the two stocks.
Get Sernova News Delivered to You Automatically
Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
